BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,099 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $261 | -69.3% | 7,750 | -60.8% | 0.10% | -71.0% |
Q1 2024 | $850 | -7.3% | 19,750 | -16.1% | 0.35% | -11.5% |
Q4 2023 | $917 | +55.2% | 23,550 | +51.4% | 0.39% | +37.4% |
Q3 2023 | $591 | -12.6% | 15,550 | +5.4% | 0.29% | -7.7% |
Q2 2023 | $676 | -6.6% | 14,750 | -16.9% | 0.31% | -14.1% |
Q1 2023 | $724 | +10.7% | 17,750 | +39.2% | 0.36% | +0.3% |
Q4 2022 | $654 | -99.9% | 12,750 | 0.0% | 0.36% | -9.1% |
Q3 2022 | $690,000 | -16.2% | 12,750 | 0.0% | 0.40% | -12.0% |
Q2 2022 | $823,000 | +36.5% | 12,750 | +64.5% | 0.45% | +63.6% |
Q1 2022 | $603,000 | -9.6% | 7,750 | 0.0% | 0.28% | -1.4% |
Q4 2021 | $667,000 | +6.5% | 7,750 | 0.0% | 0.28% | -4.8% |
Q3 2021 | $626,000 | 0.0% | 7,750 | 0.0% | 0.29% | +3.9% |
Q2 2021 | $626,000 | -5.2% | 7,750 | -0.6% | 0.28% | -12.4% |
Q1 2021 | $660,000 | +5.1% | 7,800 | 0.0% | 0.32% | +1.6% |
Q4 2020 | $628,000 | -0.2% | 7,800 | 0.0% | 0.32% | -9.7% |
Q3 2020 | $629,000 | -6.5% | 7,800 | 0.0% | 0.35% | -19.5% |
Q2 2020 | $673,000 | +6.0% | 7,800 | 0.0% | 0.44% | -14.5% |
Q1 2020 | $635,000 | -2.9% | 7,800 | 0.0% | 0.51% | +19.2% |
Q4 2019 | $654,000 | -4.4% | 7,800 | 0.0% | 0.43% | -13.4% |
Q3 2019 | $684,000 | +6.9% | 7,800 | 0.0% | 0.49% | +4.9% |
Q2 2019 | $640,000 | +0.8% | 7,800 | 0.0% | 0.47% | +1.1% |
Q1 2019 | $635,000 | +23.3% | 7,800 | 0.0% | 0.47% | +9.6% |
Q4 2018 | $515,000 | -14.6% | 7,800 | 0.0% | 0.42% | +2.7% |
Q3 2018 | $603,000 | +4.5% | 7,800 | 0.0% | 0.41% | -4.2% |
Q2 2018 | $577,000 | -99.9% | 7,800 | 0.0% | 0.43% | +11.9% |
Q1 2018 | $508,560,000 | +0.6% | 7,800 | 0.0% | 0.39% | +6.9% |
Q4 2017 | $505,440,000 | +3.3% | 7,800 | 0.0% | 0.36% | -1.6% |
Q3 2017 | $489,450,000 | – | 7,800 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |